|
Jul 22
|
1 Volatile Stock to Own for Decades and 2 We Brush Off
|
|
Jul 15
|
First Patient Enrolled in National Cancer Institute’s Vanguard Study Evaluating Guardant Health’s Shield Multi-Cancer Detection Test
|
|
Jul 14
|
Guardant Health to Report Second Quarter 2025 Financial Results on July 30, 2025
|
|
Jun 30
|
The 5 Most Interesting Analyst Questions From Guardant Health’s Q1 Earnings Call
|
|
Apr 10
|
Guardant Health to Report First Quarter 2025 Financial Results on April 30, 2025
|
|
Apr 8
|
Reflecting On Testing & Diagnostics Services Stocks’ Q4 Earnings: Guardant Health (NASDAQ:GH)
|
|
Feb 22
|
Guardant Health price target raised to $56 from $42 at TD Cowen
|
|
Feb 22
|
Guardant Health Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
|
Feb 21
|
These Biotech Stocks Aren't Profitable But Still Make Elite IBD 50
|
|
Feb 21
|
What's Going On With Cancer Diagnostic Firm Guardant Health On Friday?
|
|
Feb 21
|
Guardant Health Inc (GH) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
|
|
Feb 20
|
Guardant Health (GH) Reports Q4 Earnings: What Key Metrics Have to Say
|
|
Feb 20
|
Guardant Health (GH) Reports Q4 Loss, Tops Revenue Estimates
|
|
Feb 20
|
Guardant Health: Q4 Earnings Snapshot
|
|
Feb 20
|
Guardant Health Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 Outlook
|
|
Feb 19
|
Why Guardant Health, Inc. (GH) is the Best Performing Healthcare Stock So Far in 2025
|
|
Feb 17
|
Will Fate Therapeutics (FATE) Report Negative Q4 Earnings? What You Should Know
|
|
Feb 17
|
Exploring Analyst Estimates for Guardant Health (GH) Q4 Earnings, Beyond Revenue and EPS
|
|
Feb 13
|
Guardant Health (GH) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
|
|
Feb 11
|
Here's Why Guardant Health (GH) Is a Great 'Buy the Bottom' Stock Now
|